home / stock / bvxv / bvxv news


BVXV News and Press, BiondVax Pharmaceuticals Ltd. From 08/01/23

Stock Information

Company Name: BiondVax Pharmaceuticals Ltd.
Stock Symbol: BVXV
Market: NASDAQ

Menu

BVXV BVXV Quote BVXV Short BVXV News BVXV Articles BVXV Message Board
Get BVXV Alerts

News, Short Squeeze, Breakout and More Instantly...

BVXV - Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules

JERUSALEM, Aug. 01, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, toda...

BVXV - BioMedNewsBreaks - BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leveraging Unique NanoAb Pipeline to Target Large, Growing Markets

BiondVax (NASDAQ: BVXV) is an innovative biotechnology company focused on developing, manufacturing and commercializing potential blockbuster immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company is developing a pipeline of unique nanosized ant...

BVXV - Review Shows AI Could Be Pivotal in Infectious Disease Prevention

The worst of the coronavirus pandemic may be in the past, but it showed just how badly a fast-spreading infectious disease could affect the world. Most countries were woefully unprepared to deal with a medical event of that magnitude, and for the most part, the world still isn’t equipped...

BVXV - M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

BiondVax, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, was featured in a recent analyst report reiterating a Buy recommendation and a $70 target price The report discussed Eli Lilly’s announcement of a definitive...

BVXV - BioMedNewsBreaks - BiondVax Pharmaceuticals Ltd.'s (NASDAQ: BVXV) CDMO Services Designed to Meet Needs of Pharmaceutical, Biotechnology Companies of All Sizes

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company recently showcased its boutique end-to-end contract development and man...

BVXV - Psoriasis Could Be Behind Frequent Fatigue

Psoriasis is a topical condition that causes dry, scaly and itchy patches to develop on the skin around the scalp, trunk, elbows and knees. The condition is chronic and is typically managed using medication to alleviate symptoms, coping strategies and different lifestyle habits to minimize the ...

BVXV - BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) CEO Amir Reichman Featured on IBN's The Bell2Bell Podcast

Reichman discusses BiondVax’s 2023 achievements, including the development of innovative NanoAbs in collaboration with the Max Planck Institute targeting interleukin-17 (IL-17) targeting diseases such as psoriasis Annual sales for current anti-interleukin-17 monoclonal antibodies now tot...

BVXV - Shining the Spotlight on Asthma During Pregnancy

Asthma is a respiratory condition that affects around 9.7% of adult women and 6.2% of adult males. Researchers believe the condition is more prevalent in girls and women as fluctuating levels of hormones, including progesterone and estrogen, can affect a woman’s airways. For women with...

BVXV - Study Links Gut Flora to Onset of Pediatric Rheumatism

The human body comprises many complex and interconnected systems that rely on and affect each other in myriad ways. One of the most complex systems is the gut biome , a collection of bacteria that live in the digestive tract and have a symbiotic relationship with humans. The gut biome is made ...

BVXV - InvestorNewsBreaks - BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in Bell2Bell Podcast

BiondVax (NASDAQ: BVXV) , a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, was featured in the latest episode of the Bell2Bell Podcast . The podcast is part of...

Previous 10 Next 10